If the same is true in MPNST, the elevated expression of FOXM1 would be expected to suppress FOXO1 transcription, thus downregulating expression of the FOXO1 protein and impairing its induction of CDK inhibitors (Figure 4). The gene discussed is FOXM1; the disease is malignant peripheral nerve sheath tumor.